Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 8/20 | 0.45 |
| ▸ | AKT2 | P31751 | 7/20 | 0.45 |
| ▸ | AKT3 | Q9Y243 | 6/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 10/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 6/20 | 0.44 |
| ▸ | GSK3B | P49841 | 3/20 | 0.40 |
| ▸ | RPS6KA5 | O75582 | 2/20 | 0.40 |
| ▸ | RPS6KA4 | O75676 | 2/20 | 0.40 |
| ▸ | PRKACA | P17612 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | PRKX | P51817 | 2/20 | 0.40 |
| ▸ | PRKG1 | Q13976 | 2/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.40 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.40 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.40 |
| ▸ | SGK2 | Q9HBY8 | 1/20 | 0.40 |
| ▸ | ECE1 | P42892 | 1/20 | 0.40 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3606006 | 0.89 | ROCK2 (0.40) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL3606013 | 0.89 | ROCK2 (0.40) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL15005524 | 0.84 | ROCK2 (0.38) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL15005503 | 0.84 | ROCK2 (0.38) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL3599560 | 0.83 | ROCK2 (0.47) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL3597451 | 0.79 | ROCK2 (0.40) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL3601278 | 0.78 | ROCK2 (0.38) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL3606901 | 0.77 | ROCK2 (0.37) | AKT1AKT2AKT3ROCK2ROCK1 | |
| SCHEMBL3597400 | 0.74 | KDM4C (0.38) | ROCK2 | |
| SCHEMBL3604129 | 0.73 | SIRT3 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2118102-B1 | TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES | NERVIANO MEDICAL SCIENCES SRL (IT) | 2013-06-12 | — | — | EP | claimed |
| US-8207180-B2 | Tricyclic indoles and (4,5-dihydro) indoles | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2012-06-26 | — | — | US | claimed |
| EP-2118102-B1 | TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES | NERVIANO MEDICAL SCIENCES SRL (IT) | 2013-06-12 | — | — | EP | disclosed |
| US-8207180-B2 | Tricyclic indoles and (4,5-dihydro) indoles | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2012-06-26 | — | — | US | disclosed |
| US-20100075998-A1 | TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100075998-A1 | TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES | CDC7, CDK7, CDK17 | AKT1 47/4885AKT2 57/4885AKT3 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.